Physician profile
Manikandan Sugumaran
NPI 1932356367
$5,814.99
in general payments reported to CMS, 2019-2025
17 companies · $1,817 in 2025
The $1,817 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,937 · 2020: $182 · 2021: $161 · 2022: $41.88 · 2023: $526 · 2024: $151 · 2025: $1,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,494 · Food and Beverage: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,494.00 |
| Food and Beverage | $999.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,730.38 | 2019-2021 | |
| Amgen INC. | $1,494.00 | 2025 | Tavneos |
| Stryker Corporation | $454.24 | 2019-2025 | Audion Et Dilation System, Medline Industries, INC., 1788 |
| Genzyme Corporation | $213.11 | 2019-2025 | |
| Glaxosmithkline, LLC. | $167.20 | 2023-2025 | Nucala |
| Tactile Systems Technology INC | $149.07 | 2023 | Entre Plus, Flexitouch Plus |
| Boston Scientific Corporation | $121.41 | 2020 | |
| Karl Storz Endoscopy-America | $115.21 | 2019 | |
| Medtronic, INC. | $79.16 | 2021 | |
| Optinose US, INC. | $59.86 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $50.45 | 2019-2024 | Dupixent |
| Medtronic USA, INC. | $47.91 | 2020 | |
| Merck Sharp & Dohme LLC | $45.83 | 2022-2023 | |
| Precigen, INC. | $34.52 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $18.50 | 2023 | Seglentis |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.09 | 2023 | Coblation, Halo, Tula |
| Hologic Sales and Service, LLC | $16.05 | 2025 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manikandan Sugumaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.